Pyrimidine Biosynthesis and Degradation (Catabolism)

Encyclopedia of Biological Chemistry: Second Edition

Volumn , Issue , 2013, Pages 712-718

  Loffler M ^a   Zameitat, E ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Compartmentalization; Cytidine; De novo synthesis; Degradation; Deoxyribonucleotides; Enzyme deficiencies; Inherited disorders; Multienzymes; Neurologic disorders; Pyrimidines; Ribonucleotides; Salvage; Thymidine; Uridine

Indexed keywords

EID: 85000861246     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-378630-2.00178-X     Document Type: Chapter

References (17)

1. Arnér E.S., Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacology and Therapeutics 1995, 67:155-186.
2. Carrey E.A. Key enzymes in the biosynthesis of purines and pyrimidines: Their regulation by allosteric effectors and by phosphorylation. Biochemical Society Transactions 1995, 23:899-902.
3. Connolly G.P., Duley J.A. Uridine and its nucleotides: Biological actions, therapeutic potentials. Trends in Biochemical Sciences 1999, 20:218-225.
4. Evans D.R., Guy H.I. Mammalian pyrimidine biosynthesis: Fresh insights into an ancient pathway. Journal of Biological Chemistry 2004, 279:33035-33038.
5. Follmann H. Deoxyribonucleotides: The unusual chemistry and biochemistry of DNA precursors. Chemical Society Reviews 2004, 33:225-233.
6. Fox B., Bzik D.J. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii. Nature 2002, 415:926-929.
7. Hatse S., DeClercq E., Balzarini J. Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation. Biochemical Pharmacology 1999, 58:539-555.
8. Jones M.E. Pyrimidine nucleotide biosynthesis in animals:genes, enzymes, and regulation of UMP biosynthesis. Annual Review of Biochemistry 1980, 49:253-279.
9. Lee M., Maher M.J., Christopherson R.I. Dihydroorotase inhibitors. Drug Design of Zn-Enzyme Inhibitors 2009, 949-977. Wiley, New York, NY. C.T. Supuran, J.Y. Winum (Eds.).
10. Löffler M., Fairbanks L., Zameitat E., Marinaki T., Simmonds A. Pyrimidine pathways in health and disease. Trends in Molecular Medicine 2005, 11:430-437.
11. Piskur J., Sandrini M.P., Knecht W., Munch-Petersen B. Animal deoxyribonucleoside kinases: Forward and retrograde evolution of their substrate specificity. FEBS Letters 2004, 560:3-6.
12. Piskur J., Schnackerz K.D., Andersen G., Björnberg O. Comparative genomics reveals novel biochemical pathways. Trends in Genetics 2007, 23:369-372.
13. Schaefer C.M., Schäfer M.K.H., Löffler M. Region-specific distribution of dihydroorotate dehydrogenase in the rat central nervous system points to pyrimidine de novo synthesis in neurons. Nucleosides Nucleotides Nucleic Acids 2010, 29:476-481.
14. Stubbe J.A. Ribonucleotide reductases in the twenty-first century. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:2723-2724.
15. Van Kuilenburg A.B.P., Van Lenthe H., Löffler M., Van Gennip A.H. Analysis of pyrimidine synthesis de novo intermediates in urine and dried filter stripes with HPLC tandem mass spectrometry. Clinical Chemistry 2004, 50:2117-2124.
16. Voet D., Voet J.G. Biochemistry 2004, Wiley, New York, NY. 3rd edn.
17. Webster D., Becroft D.M.O., Van Gennip A.H., Van Kuilenburg A.B.P. Hereditary orotic aciduria and other disorders of pyrimidine metabolism. The Metabolic and Molecular Bases of Inherited Disease 2001, vol II:2663-2702. McGraw-Hill, New York, NY. 8th edn. C.R. Scriver (Ed.).